Stifel Maintains Hold on IDEXX Laboratories, Lowers Price Target to $460
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Jonathan Block has maintained a 'Hold' rating on IDEXX Laboratories (NASDAQ:IDXX) and lowered the price target from $500 to $460.
October 30, 2023 | 3:10 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Stifel analyst has maintained a 'Hold' rating on IDEXX Laboratories and lowered the price target from $500 to $460.
The news directly pertains to IDEXX Laboratories as the analyst from Stifel has maintained a 'Hold' rating on the company and lowered the price target. This could potentially impact the stock's performance in the short term as it might influence investors' decisions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100